MedPath

青海可可西里药业集团有限公司

Ownership
-
Established
2005-06-22
Employees
-
Market Cap
-
Website
https://www.qhkkxl.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

七味螃蟹甲丸

Approval Number
国药准字Z20093694
Approval Date
Nov 12, 2019
NMPA

六味地黄丸

Approval Number
国药准字Z20093692
Approval Date
Nov 12, 2019
NMPA

清脑降压片

Approval Number
国药准字Z20093638
Approval Date
Sep 3, 2019
NMPA

Ligustrazine Phosphate Capsules

Product Name
磷酸川芎嗪胶囊
Approval Number
国药准字H20093849
Approval Date
Sep 3, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.